Arix Bioscience Plc Issue of Ordinary Shares, TVR, PDMR Shareholding (1503A)
December 22 2017 - 2:00AM
UK Regulatory
TIDMARIX
RNS Number : 1503A
Arix Bioscience Plc
22 December 2017
22 December 2017
Arix Bioscience plc
Issue of Ordinary Shares, Total Voting Rights and Director/PDMR
Shareholding Notifications
Arix Bioscience plc (the "Company") announces that it has
allotted New Ordinary Shares to two non-executive directors, in
accordance with the compensation agreed at their appointments, as
follows:
Name of executive Number of shares
director allotted
Meghan FitzGerald 30,344
Giles Kerr 31,663
Application has been made for the 62,007 New Ordinary Shares to
be admitted to the standard segment of the Official List and to
trading on the Main Market of the London Stock Exchange. The new
Ordinary Shares will rank pari passu with the existing ordinary
shares and it is expected that admission of these New Ordinary
Shares will take place at 8.00 a.m. on 28 December 2017.
Following the issue of 62,007 shares the Company will have a
total of 96,153,090 ordinary shares of GBP0.00001 each in issue and
a total number of voting rights in the Company of 96,153,090. The
above figure of 96,153,090 may be used by shareholders as the
denominator for the calculation by which they may determine if they
are required to notify their interest in, or change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
PDMR DEALING NOTIFICATION
-----------------------------------------------------------------------------------
Notification and public disclosure of transactions
by persons discharging managerial responsibilities
and persons closely associated with them
-----------------------------------------------------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- -----------------------------------------------------------------------------
a) Name Meghan FitzGerald
---- ---------------------- -----------------------------------------------------
2 Reason for the notification
---- -----------------------------------------------------------------------------
a) Position Non Executive Director
/ status
---- ---------------------- -----------------------------------------------------
b) Initial notification Initial Notification
/
Amendment
---- ---------------------- -----------------------------------------------------
3 Details of issuer
---- -----------------------------------------------------------------------------
a) Name Arix Bioscience plc
---- ---------------------- -----------------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---- ---------------------- -----------------------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -----------------------------------------------------------------------------
a) Description Ordinary Shares of Arix Bioscience
of the financial plc
instrument,
type of instrument
---- ---------------------- -----------------------------------------------------
Identification GB00BD045071
code
---- ---------------------- -----------------------------------------------------
b) Nature of Award of Ordinary Shares
the transaction
---- ---------------------- -----------------------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s)
---- ---------------------- -------------------------- -------------------------
GBP1.895 30,344
------------------------------------------------------ -------------------------
d) Aggregated Aggregated price Aggregated volume
information
---- ---------------------- -------------------------- -------------------------
N/A (single transaction) N/A (single transaction)
------------------------------------------------------ -------------------------
e) Date of the 21 December 2017
transaction
---- ---------------------- -----------------------------------------------------
f) Place of London Stock Exchange (XLON)
the transaction
---- ---------------------- -----------------------------------------------------
PDMR DEALING NOTIFICATION
-----------------------------------------------------------------------------------
Notification and public disclosure of transactions
by persons discharging managerial responsibilities
and persons closely associated with them
-----------------------------------------------------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- -----------------------------------------------------------------------------
a) Name Giles Kerr
---- ---------------------- -----------------------------------------------------
2 Reason for the notification
---- -----------------------------------------------------------------------------
a) Position Non Executive Director
/ status
---- ---------------------- -----------------------------------------------------
b) Initial notification Initial Notification
/
Amendment
---- ---------------------- -----------------------------------------------------
3 Details of issuer
---- -----------------------------------------------------------------------------
a) Name Arix Bioscience plc
---- ---------------------- -----------------------------------------------------
b) LEI 213800OVT3AHQCXNIX43
---- ---------------------- -----------------------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -----------------------------------------------------------------------------
a) Description Ordinary Shares of Arix Bioscience
of the financial plc
instrument,
type of instrument
---- ---------------------- -----------------------------------------------------
Identification GB00BD045071
code
---- ---------------------- -----------------------------------------------------
b) Nature of Award of Ordinary Shares
the transaction
---- ---------------------- -----------------------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s)
---- ---------------------- -------------------------- -------------------------
GBP1.895 31,663
------------------------------------------------------ -------------------------
d) Aggregated Aggregated price Aggregated volume
information
---- ---------------------- -------------------------- -------------------------
N/A (single transaction) N/A (single transaction)
------------------------------------------------------ -------------------------
e) Date of the 21 December 2017
transaction
---- ---------------------- -----------------------------------------------------
f) Place of London Stock Exchange (XLON)
the transaction
---- ---------------------- -----------------------------------------------------
For further information:
James Rawlingson Chief Financial Officer +44 (0)207 290 1050
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFMMZZGMNGNZZ
(END) Dow Jones Newswires
December 22, 2017 02:00 ET (07:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2023 to Apr 2024
